• Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company) announces encouraging preclinical proof of concept data at a poster presentation at the American Association for Cancer Research (AACR) 2023 Annual Meeting being held April 14 - 19, 2023 in Orlando, Florida. (biospace.com)
  • Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company) announced today the first ever data demonstrating the utility of Actimab-A to depleted myeloid derived suppressor cells (MDSCs), which are ubiquitously present within the solid tumor microenvironment as well as blood cancers. (biospace.com)
  • NEW YORK , Jan. 23, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or "the Company") announced today the appointment of Cynthia Pussinen as Executive Vice President, Technical Operations and Supply Chain. (prnewswire.com)
  • Sandesh Seth, CEO & Chairman of the Board of Actinium Pharmaceuticals (NASDAQ: ATNM), was recently a guest on Benzinga's All-Access. (thepilotnews.com)
  • NEW YORK , Sept. 8, 2022 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company) a leader in the development of targeted radiotherapies for patients with unmet needs, today announced that it will be participating in the H.C. Wainwright 24th Annual Global Investment Conference, being held September 12-14, 2022. (actiniumpharma.com)
  • Articles about Actinium Pharmaceuticals, Inc. (biospace.com)
  • Actinium Pharmaceuticals, Inc. (biospace.com)
  • Actinium Pharmaceuticals, Inc. today announced that the positive results from the pivotal Phase 3 SIERRA Trial of Iomab-B were presented in an oral presentation at the European Society for Blood and Marrow Transplantation (EBMT) 49th Annual Meeting that was held in Paris, France April 23 - 26, 2023. (biospace.com)
  • Actinium Pharmaceuticals, Inc., a leader in the development of targeted radiotherapies, reported its financial results for the quarter and year ended December 31, 2022, and provided a corporate update. (biospace.com)
  • Actinium Pharmaceuticals, Inc. announced today that two abstracts have been accepted for presentation at the American Association for Cancer Research (AACR) 2023 Annual Meeting being held April 14 - 19, 2023 in Orlando, Florida. (biospace.com)
  • Actinium Pharmaceuticals, Inc. today announced that the Company's management team will participate in a virtual presentation at Oppenheimer's 33rd Annual Healthcare Conference being held March 13-17, 2023. (biospace.com)
  • Actinium Pharmaceuticals today announced that it will host a key opinion leader (KOL) webinar at 8 a.m. (biospace.com)
  • Actinium Pharmaceuticals' Iomab-B met the primary endpoint in the Phase III SIERRA trial, demonstrating durable Complete Remission at six months. (biospace.com)
  • Actinium Pharmaceuticals, Inc. announced positive results for the primary and secondary endpoints from its pivotal Phase 3 SIERRA trial of Iomab-B in patients age 55 and above with active relapsed or refractory acute myeloid leukemia. (biospace.com)
  • Actinium Pharmaceuticals, Inc. today announced its presence at the upcoming Tandem Meetings: Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) being held February 15 - 19, 2023 at the World Center Marriott in Orlando, Florida. (biospace.com)
  • Actinium Pharmaceuticals, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), part of the National Institutes for Health (NIH), to develop Actimab-A for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies. (biospace.com)
  • About Actinium Pharmaceuticals. (niche.com)
  • Iodine i 131 apamistamab is under clinical development by Actinium Pharmaceuticals and currently in Phase II for Myelodysplastic Syndrome. (pharmaceutical-technology.com)
  • Actinium Pharmaceuticals (Actinium) develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. (pharmaceutical-technology.com)
  • Wie kann man Actinium Pharmaceuticals Inc-Aktien kaufen? (fibogroup.com)
  • Um mit Actinium Pharmaceuticals Inc zu handeln, müssen Sie ein Konto eröffnen, die Handelsplattform installieren, den Markt analysieren, technische Indikatoren verwenden und auf der Grundlage Ihrer Analyse eine Kauf- oder Verkaufsorder erteilen. (fibogroup.com)
  • Was ist der Actinium Pharmaceuticals Inc-Aktientrend? (fibogroup.com)
  • Anleger können die Marktentwicklung von Actinium Pharmaceuticals Inc auf Online-Handelsplattformen anhand von Echtzeit-Charts und Live-Kursnotierungen verfolgen. (fibogroup.com)
  • Da der Preis Schwankungen aufgrund von Angebot und Nachfrage unterliegt, ist Actinium Pharmaceuticals Inc eine bevorzugte Option für Trader, die von der Volatilität profitieren möchten. (fibogroup.com)
  • What's Going On With Actinium Pharmaceuticals Stock? (thepilotnews.com)
  • As part of a preferred partner agreement, Fusion Pharmaceuticals has appointed BWXT Medical, a subsidiary of BWX Technologies, to supply it with predetermined amounts of actinium-225 for the production of targeted alpha therapies (TATs) for cancer treatments. (dotmed.com)
  • Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with high unmet needs not addressed by traditional cancer therapies. (actiniumpharma.com)
  • Forward-Looking Statements for Actinium Pharmaceuticals, Inc. (actiniumpharma.com)
  • Actinium Pharmaceuticals' drug development pipeline features Iomab-B, which completed enrollment of its pivotal Phase 3 clinical trial, Iomab-ACT, which is intended to be a conditioning regimen for cell and gene therapies that is being studied in an NIH funded clinical study and Actimab-A, which is being studied in two combination trials for relapsed/refractory AML. (actiniumpharma.com)
  • Topline data from the SIERRA trial is expected in the fourth quarter of 2022. (actiniumpharma.com)
  • In April 2022, Actinium announced Immedica licensed the rights to commercialize Iomab-B (1-131 apamistamab) in the EU, Middle East and North Africa. (actiniumpharma.com)
  • In February 2022, Actinium and AVEO entered into a research collaboration to develop a first in class HER3 (ErbB3) targeting radiotherapy using the Actinium-225 radioisotope warhead for solid tumors. (actiniumpharma.com)
  • The term refers to the heaviest elements, starting with actinium and continuing to the end of the periodic table. (cdc.gov)
  • actinium isotopes are then chemically purified in hot cells and 225Ac is concentrated. (wikipedia.org)
  • Through decades of experience, Behrenbruch and Kluge have seen the evolution and growth of radiopharmaceutical approaches to diagnostics and therapeutics, along with the development of new supply chains for isotopes such as Lutetium-177, Actinium-225 and Gallium-68. (appliedradiology.com)
  • Actinia Accommodation is an apartment located right in the centre of Alghero. (actiniabb.com)
  • Actinium plans to advance Iomab-B for other blood cancers and next generation conditioning candidate Iomab-ACT to improve cell and gene therapy outcomes. (actiniumpharma.com)
  • Actinium is focused on continuing to expand its drug development pipeline of targeted radiotherapies for patients with blood cancers and solid tumors. (actiniumpharma.com)
  • Our AWE technology platform is currently being utilized in collaborative research partnerships with Astellas Pharma, Inc. for solid tumor theranostics, with AVEO Oncology to create an Actinium-225 HER3 targeting radiotherapy for solid tumors, and with EpicentRx, Inc.to create targeted radiotherapy combinations with their novel, clinical stage small molecule CD47-SIRPα inhibitor. (actiniumpharma.com)
  • At the Society of Immunotherapy for Cancer (SITC) meeting in November 2021 and American Association for Cancer Research (AACR) we presented the first ever data combining targeted radiotherapy with a CD47 immunotherapy, magrolimab which is being developed by Gilead Sciences, and showed that targeted radiotherapy increased cell surface calreticulin and "eat me" signal that resulted in increased phagocytosis and enhanced tumor growth inhibition. (actiniumpharma.com)
  • Since 2018, TerraPower has been working to increase the supply of Actinium-225 from Thorium-229 decay, which is derived from Uranium-233 managed by the U.S. Department of Energy. (terrapower.com)
  • Dabei sind die openEO Endpunkte für die Entdeckung der Daten (EO Data Discovery) kompatibel zu STAC, so dass bei einer Implementierung beide Konzepte wunderbar zusammenspielen können. (ccc.de)
  • Sandesh Seth , Actinium's Chairman and CEO, said, "We are excited to present data from our Ac-225 clinical programs and AWE platform at the preeminent conference focused on targeted alpha-particle therapies. (prnewswire.com)
  • Actinium is advancing the only multi-disease, multi-target, clinical-stage pipeline for targeted conditioning to enable cellular therapies such as BMT or Bone Marrow Transplant (BMT) and CAR-T. The target market for Actinium's ARC or Antibody Radiation Conjugate drug candidates is concentrated within the top 75-100 hospitals in the U.S. that perform a majority of BMT and CAR-T procedures. (prnewswire.com)
  • Actinium develops targeted radiotherapies to meaningfully improve survival for people who have failed existing oncology therapies. (actiniumpharma.com)
  • Excitement for the potential of targeted alpha therapies to treat cancer is growing, and we have made the necessary investments in infrastructure and intellectual property to help meet the increasing global demand for actinium," said BWXT Medical president and chief executive officer Jonathan Cirtain. (dotmed.com)
  • In addition, we are leaders in the field of Actinium-225 alpha therapies. (actiniumpharma.com)
  • Should the targeting properties of this PET/CT imaging tracer be established in TNBC, Telix's intention is to broaden future applications for lutetium-177 and actinium-225 based CAIX therapies. (aap.com.au)
  • Dieser Vortrag zeigt am Beispiel von [actinia](https://github.com/mundialis/actinia_core) und dem [openeo-grassgis-driver](https://github.com/Open-EO/openeo-grassgis-driver), wie so eine Implementierung aussehen kann. (ccc.de)
  • tool ( details ) allows the execution of a single GRASS GIS command or a list of GRASS GIS commands on an actinia REST service ( https://actinia.mundialis.de/ ). (osgeo.org)
  • For more information, please visit Astellas' website at https://www.astellas.com/en . (actiniumpharma.com)
  • Alpha emitters such as actinium-225 are favored in cancer treatment because of the short range (a few cell diameters) of alpha particles in tissue and their high energy, rendering them highly effective in targeting and killing cancer cells-specifically, alpha particles are more effective at breaking DNA strands. (wikipedia.org)
  • Based on emerging clinical data in the literature which show the power of alpha particles over conventional beta emitters, we continue to proactively prioritize access to actinium as a critical component of Fusion's development plans, and we are excited to partner with BWXT Medical," said Fusion chief executive officer John Valliant in a statement. (dotmed.com)
  • Our collaboration with Radiopharm Theranostics aligns with our vision to provide broad industry access to Actinium-225, enabling partners to develop much-needed radiopharmaceuticals. (terrapower.com)
  • Actinium has forged strong partnerships with companies globally who share our vision of bringing targeted radiotherapies to patients in need. (actiniumpharma.com)
  • Àktíníọ̀m tabi Actinium je is a radioactive apilese kemika alagbararadio to ni ami-idamo Ac ati nomba atomu 89, to je wiwari ni odun 1899. (wikipedia.org)
  • Actinides - radioactive elements with atomic numbers equal to or greater than that of actinium (i.e., 88). (cdc.gov)
  • Due to its highly differentiated properties, we are increasing our research related to targeted Actinium-225 through our AWE platform to continue to drive highly differentiated programs to further expand our pipeline into areas of unmet need. (prnewswire.com)
  • data.mundialis: eine Sammlung neuer offener Datenprodukte! (ccc.de)
  • The cloud based geoprocessing platform actinia is able to ingest and analyse large volumes of geodata already present in the cloud. (europa.eu)
  • Dr. Dale Ludwig , Actinium's Chief Scientific Officer, said, "Actinium-225 is an isotope with great potential for therapeutic applications given its high energy, short pathlength and 10-day half-life. (prnewswire.com)
  • In addition to highlighting Actinium's clinical programs and AWE platform, Actinium will present a poster comparing the feasibility of using Ac-225 produced in a high-energy linear proton accelerator by the DOE or U.S. Department of Energy to that of traditional Ac-225 produced in a "thorium cow" or generator. (prnewswire.com)
  • Sandesh Seth , Actinium's Chairman and CEO said, "We are pleased to expand our core leadership team with a seasoned executive of Cynthia's caliber who has a proven ability to execute and drive growth in areas that are highly relevant to Actinium. (prnewswire.com)
  • Sandesh Seth, Actinium's Chairman and CEO, commented, "These data further increase our enthusiasm for Actimab-A's potential in solid tumor indications. (actiniumpharma.com)
  • A new endemic Actinia species (Actiniaria: Actiniidae) from the central Macaronesian Archipelagos. (marbef.org)
  • Actinia provides a REST API to process satellite images, time series of satellite images, raster and vector data. (osgeo.org)
  • Actinium received a $35 million upfront payment and is eligible to receive up to an additional $417 million in potential regulatory and sales milestones as well as royalties in the mid-twenty percent range of Iomab-B sales under the terms of the license agreement. (actiniumpharma.com)
  • The main areas of consulting are business intelligence, business processes and business integration, as well as topics such as digitization, big data, I40 and IoT. (dbplus.tech)
  • This graph shows the total number of publications written about "Actinium" by people in Harvard Catalyst Profiles by year, and whether "Actinium" was a major or minor topic of these publication. (harvard.edu)
  • Below are the most recent publications written about "Actinium" by people in Profiles. (harvard.edu)
  • Actinium has no biological role. (webelements.com)
  • 1974. In: Biological handbooks: Biology data book. (cdc.gov)
  • The Actinium-225 will be utilized in drug trials involving targeted alpha therapy in multiple disease areas. (terrapower.com)
  • Coya Therapeutics rang the closing bell at Nasdaq last week, celebrating six months since its IPO, new data from trials, and additions to its team. (innovationmap.com)
  • Preliminary data demonstrates the feasibility of girentuximab to target CAIX expression in TNBC. (aap.com.au)
  • Preliminary data from this feasibility, dosimetry and imaging study at ICO, [1] shows encouraging tumour targeting and biodistribution with TLX250-CDx, and no systemic distribution of radiation. (aap.com.au)
  • Actinium does not occur to any significant extent in the biosphere and so normally never presents a risk. (webelements.com)
  • Ms. Pussinen brings 25 years of highly relevant technical operations and supply chain experience from executive roles at global biopharmaceutical organizations Pfizer and Ipsen to Actinium. (prnewswire.com)
  • Highly in demand, only a limited number of suppliers are able to produce substantial amounts of high-purity actinium, such as BWXT Medical, which will supply Fusion with actinium at volume-based pricing. (dotmed.com)
  • With the clinical data and supply chain behind us, we can turn the fantastic work from academia into a commercial platform. (appliedradiology.com)
  • Cynthia joins Actinium from Pfizer, where she was the Head of Strategic Portfolio Management, Worldwide Research & Development. (prnewswire.com)
  • The partnership with DBPLUS aims to provide customers with precisely these competitive advantages in database performance management and data replication. (dbplus.tech)
  • Both partners are convinced that they can offer companies more simplicity and new impulses in the field of data management - and that is simply innovative. (dbplus.tech)
  • Please contact your representative at H.C. Wainwright to schedule a one-on-one meeting with the Actinium management team. (actiniumpharma.com)
  • Our novel runtime container Actinium (Ac) exposes scripts, their configuration, and their lifecycle management through a fully RESTful programming interface using the Constrained Application Protocol (CoAP). (ethz.ch)
  • GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. (pharmaceutical-technology.com)
  • GRASS GIS commands can be augmented with actinia specific extensions. (osgeo.org)
  • Note: This record shows only 22 elements of the WHO Trial Registration Data Set. (who.int)
  • Latest version of actinia is now missing from Pypi. (osgeo.org)
  • Actinium believes Actimab-A has the potential to be used in combination with immunotherapy, including immune checkpoint inhibitors, to enhance antitumor immunity via targeted MDSC depletion. (actiniumpharma.com)
  • Whilst a small patient population at this stage, early data from the OPALESCENCE study is encouraging as an indicator for future therapy applications of TLX250 and demonstrating the value of a "theranostic" approach" with this radiolabelled antibody. (aap.com.au)
  • With Actinium, applications can be created by simply mashing up resources provided by CoAP servers on devices, other scripts, and classic Web services. (ethz.ch)
  • Elements for which there are no data will always give a value of zero for the weight, no matter what you put in the weight box. (webelements.com)